Atenolol
- Product NDC
- 68382-023
- 11-digit product format
- 683820023
- Labeler code
- 68382
- Product ID
- 68382-023_860eb406-b330-4b72-b768-122d57c74293
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA076900
- Marketing category
- ANDA
- Marketing start
- 2005-10-08
- Substance
- ATENOLOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atenolol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ATENOLOL | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 50VV3VW0TI |
| Rxcui | 197379, 197380, 197381 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ATENOLOL | ACTIVE INGREDIENT | 50VV3VW0TI | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| ATENOLOL | ACTIVE MOIETY | 50VV3VW0TI | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 6 | |
| ATENOLOL | ACTIVE INGREDIENT | 50VV3VW0TI | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ATENOLOL | ACTIVE INGREDIENT | 50VV3VW0TI | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| ATENOLOL | ACTIVE MOIETY | 50VV3VW0TI | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| ATENOLOL | ACTIVE MOIETY | 50VV3VW0TI | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | ATENOLOL TABLET ATENOLOL ( ATENOLOL ) TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ATENOLOL TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68382-023 | ATENOLOL TABLET [ZYDUS PHARMACEUTICALS USA INC.] | 13 | Current NDC, Legacy NDC, 6 package rows | 20240118_db801706-1362-44c7-92ab-f584f96c7e1c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68382-023-01 | 68382002301 | 100 TABLET in 1 BOTTLE (68382-023-01) | 100 tablet | 2005-10-08 | 0000-00-00 | No | No | Current |
| 68382-023-02 | 68382002302 | 2000 TABLET in 1 BOTTLE (68382-023-02) | 2000 tablet | 2005-10-08 | 0000-00-00 | No | No | Current |
| 68382-023-10 | 68382002310 | 1000 TABLET in 1 BOTTLE (68382-023-10) | 1000 tablet | 2005-10-08 | 0000-00-00 | No | No | Current |
| 68382-023-16 | 68382002316 | 90 TABLET in 1 BOTTLE (68382-023-16) | 90 tablet | 2005-10-08 | 0000-00-00 | No | No | Current |
| 68382-023-24 | 68382002324 | 10000 TABLET in 1 BOTTLE (68382-023-24) | 10000 tablet | 2005-10-08 | 0000-00-00 | No | No | Current |
| 68382-023-40 | 68382002340 | 5000 TABLET in 1 BOTTLE (68382-023-40) | 5000 tablet | 2005-10-08 | 0000-00-00 | No | No | Current |